Sleep Apnea and Periodic Breathing

Overview

The purpose of this study is to determine the double loop index (DLI) threshold with optimal sensitivity and specificity. The investigators hypothesize that the DLI gives a better reflection of the pathophysiology of the disease than the apnea-hypopnea-index (AHI).

Full Title of Study: “Screening for Sleep Apnea Using Home Recording of the Double Loop Gain as a Measure of Periodic Breathing”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional

Detailed Description

Sleep apnea syndrome (SAS) is characterized by repetitive events of apnea and hypopnea. These events are often part of a periodic breathing pattern, in which relative hyperventilation is followed by apnea or hypopnea. Recently the investigators described the 'double-loop gain' of the respiratory control system as a measure of periodic breathing. This is a frequency-dependent variable which describes 1) the tendency of the respiratory system to oscillate at a given frequency and 2) the degree to which the relation between oscillations in ventilation and oscillations in arterial blood gas values is linear. The underlying hypothesis is that periodic breathing results from negative feedback regulation of arterial O2 and CO2 pressure through the chemoreflexes. The double-loop gain describes the gain in the negative feedback loop under the assumption that accidental changes occur in both ventilation and arterial blood gas pressures. A simple version of the double-loop gain is derived from nasal pressure changes and arterial O2 saturation. From all-night recordings, the 'double-loop index' (DLI) can be derived, which is determined by the time during which the double-loop gain exceeds a given threshold. Currently, the presence of sleep-apnea is determined by the apnea-hypopnea index (AHI), using in-hospital sleep recording. With a growing number of referrals, waiting lists for sleep registration are emerging. Screening for SAS using home-measurement of nasal pressure and SaO2 seems to be a good alternative. The investigators hypothesize that the DLI derived from these signals gives a better reflection of the pathophysiology of the disease than the AHI. As a result, the investigators expect that the DLI improves the distinction between healthy and diseased subjects in comparison to the simple counting of apneas and hypopneas. This is reflected in a higher area under the ROC curve, which describes the sensitivity and specificity of the test.

Arms, Groups and Cohorts

  • Suspected sleep apnea syndrome
    • Outpatients with suspected sleep apnea syndrome, age > 18 year

Clinical Trial Outcome Measures

Primary Measures

  • To determine DLI threshold with optimal sensitivity and specificity. The DLI threshold is the DLI value above which the test is considered positive. The optimal DLI threshold will be taken as the value that gives the highest area under the ROC curve.
    • Time Frame: 1 year

Secondary Measures

  • To test the hypothesis that the sensitivity and specificity of the screening are higher when the DLI is used instead of the AHI
    • Time Frame: 1 year
  • To assess the repeatability of the DLI using home and in-hospital recordings of nasal pressure and saturation (SaO2).
    • Time Frame: 1 year

Participating in This Clinical Trial

Inclusion Criteria

  • Suspected sleep apnea syndrome – > 18 yr – Outpatient – Able and willing to use the necessary equipment for registration of nasal pressure and O2 saturation at home Exclusion Criteria:

  • hospitalized patients – < 18 yr – Not able to use the necessary equipment

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Medical Center Alkmaar
  • Provider of Information About this Clinical Study
    • Dr. J.G. van den Aardweg, MD, Medical Center Alkmaar
  • Overall Official(s)
    • J.G. van den Aardweg, dr, Study Director, Medical Center Alkmaar
  • Overall Contact(s)
    • J.G. van den Aardweg, Dr., +3172-5482750, j.g.vanden.aardweg@mca.nl

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.